DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 132 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2016. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $9,809,000 | -70.0% | 494,149 | -71.8% | 0.10% | -70.7% |
| Q4 2017 | $32,725,000 | -13.0% | 1,750,000 | 0.0% | 0.34% | -20.1% |
| Q3 2017 | $37,625,000 | +579.3% | 1,750,000 | +360.6% | 0.42% | +302.9% |
| Q2 2016 | $5,539,000 | -33.0% | 379,932 | -11.6% | 0.10% | -32.7% |
| Q1 2016 | $8,273,000 | -68.3% | 430,000 | -60.2% | 0.16% | -66.9% |
| Q4 2015 | $26,115,000 | -1.5% | 1,080,944 | 0.0% | 0.47% | -12.1% |
| Q3 2015 | $26,525,000 | +1.1% | 1,080,944 | -3.4% | 0.54% | +6.3% |
| Q2 2015 | $26,224,000 | -3.3% | 1,119,533 | -7.4% | 0.50% | -1.4% |
| Q1 2015 | $27,106,000 | +36.8% | 1,208,484 | +2.8% | 0.51% | +32.6% |
| Q4 2014 | $19,817,000 | – | 1,175,392 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,415,000 | $105,945,000 | 12.42% |
| Chicago Capital, LLC | 5,842,906 | $73,562,000 | 4.06% |
| PFM Health Sciences, LP | 3,805,370 | $47,910,000 | 1.83% |
| Rhenman & Partners Asset Management AB | 800,000 | $10,072,000 | 1.14% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,320,000 | $29,209,000 | 0.71% |
| Rock Springs Capital Management LP | 1,681,458 | $21,170,000 | 0.62% |
| FEDERATED HERMES, INC. | 16,022,731 | $201,726,000 | 0.55% |
| FIRETHORN WEALTH PARTNERS, LLC | 47,376 | $665,000 | 0.54% |
| Jackson Creek Investment Advisors LLC | 82,435 | $1,185,000 | 0.48% |
| OBERWEIS ASSET MANAGEMENT INC/ | 137,200 | $1,727,000 | 0.44% |